ArticleMolecular diversity2023

Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase.

Khurshid Jalal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.